Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126362271 | 12636227 | 1 | I | 20160801 | 20160809 | 20160809 | EXP | IE-DSJP-DSE-2016-126354 | DAIICHI | HYLAND N; MCLOUGHLIN R. UNUSUAL FOR THE COMMON OR USUAL FOR THE RARE?: COELIAC DISEASE VS SYSTEMIC MASTOCYTOSIS. IRISH JOURNAL OF MEDICAL SCIENCE. 2016;185 (PP S241) | 0.00 | Y | 0.00000 | 20160809 | MD | IE | IE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126362271 | 12636227 | 1 | PS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | Y | 21286 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126362271 | 12636227 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126362271 | 12636227 | OT |
126362271 | 12636227 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126362271 | 12636227 | Malabsorption | |
126362271 | 12636227 | Systemic mastocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |